Luminex’s Flexible SARS-CoV-2 Assays Enable Both High-Throughput and Emergency Testing

Federal funding and FDA Emergency Use Authorization streamlined development and commercialization of these new assays. As the COVID-19 pandemic swept across the globe, people everywhere have raced to respond. The Luminex team has been working around the clock on much-needed molecular diagnostic assays for the SARS-CoV-2 virus, two of which recently received Emergency Use Authorization […]

Read More…

At ASM Microbe, Attention on Reimbursement and Drug-Resistant Pathogens

Luminex workshop offered a look at flexible molecular testing for GI cases We’re finally recovering from the whirlwind that is ASM Microbe, the annual mega-conference of the American Society for Microbiology. This year, the event took place in sunny San Francisco, bringing thousands of microbial experts together to discuss the latest advances and challenges in […]

Read More…

Riverview Health Shares How They Are Managing Antibiotic Resistance Through Improved Testing and Teamwork

Riverview Health is a full-service, CLIA certified, and CAP accredited laboratory. They provide clinical testing services for hospitalized patients 24 hours a day, seven days a week, and serve as a reference laboratory for doctors’ offices and extended care facilities throughout central Indiana. Diagnostic labs require accurate testing and rapid turnaround time Riverview is unique […]

Read More…

Reimbursement Advice for Labs Running Molecular Diagnostics

CLP Magazine article offers pro tips and a look at the current landscape If you work with molecular diagnostics, you probably also spend a good amount of time thinking about reimbursement. A new article in the March issue of CLP Magazine from Luminex’s resident reimbursement expert, Stephanie Ibbotson, offers practical advice and education about how […]

Read More…

WHO Report Offers Global View of Antibiotic Consumption

New resource could help shed light on growing threat of antibiotic resistance It’s no secret that antibiotic resistance is a major public health threat — but what hasn’t been well known is how antibiotics are consumed around the world. A newly issued report from the World Health Organization (WHO) offers a detailed look at antibiotic […]

Read More…

New White Paper: Molecular Testing for Gastroenteritis

Download today for real-world clinical lab results, IDSA guideline highlights, and more If gastroenteritis testing falls under your purview, don’t miss this new white paper about how molecular testing is changing the landscape of how patients are diagnosed and treated. The paper, “Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases,” is […]

Read More…

Raising RSV Awareness: The ‘Minor Cold’ That Can Threaten Your Baby’s Life

Luminex teammate Victoria Gutierrez shares her son’s fight with RSV If you have young kids, you’re probably a germ-fighting ninja during flu season. You know all about the common cold and whooping cough. But are you familiar with respiratory syncytial virus (RSV)? RSV is incredibly dangerous for little kids, but most people have never even heard […]

Read More…

Webinar Wednesday: For Tracking Anti-Apoptosis Proteins, Scientists Turn to Multiplexing

AbbVie team uses Luminex-based immunoassay for drug discovery applications According to Dr. Lloyd Lam, a senior scientist at AbbVie, measuring the expression of anti-apoptotic proteins such as BCL-2 is an easier and more cost-effective task when done with a multiplex immunoassay. Lam spoke in a Nature webinar entitled “Multiplex assays of the anti-apoptotic BCL-2 family,” […]

Read More…

Webinar: How a Community Hospital Saved $600,000 with Rapid Diagnostics

Rapid results help medical teams avoid unnecessary use of broad-spectrum antibiotics Rapid diagnostic testing is a critical component of successful antimicrobial stewardship programs, according to an expert from Blount Memorial Hospital in Maryville, Tennessee. In a recent webinar, Clinical Pharmacy Specialist Brad Crane shared his story of implementing rapid diagnostic testing at his non-teaching community […]

Read More…

ARIES® GBS Assay Outperforms Culture Testing in a Multisite Study

Results show excellent clinical performance, sensitivity, specificity, reproducibility, and ease of use A new publication released in the Journal of Clinical Microbiology reports results of a multisite analysis of the ARIES® GBS Assay. Lead author Diana R. Hernandez from Geisinger, senior author Arundhati Rao from Baylor Scott and White Health, and collaborators issued their findings […]

Read More…